While SNA directly represses epithelial markers like E-cadherin, it also upregulates the mesenchymal markers, including vimentin, fibronectin, and matrix metalloproteinases (MMP-9) in HCC [8,9,10]. The gene discussed is FN1; the disease is hepatocellular carcinoma.